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Aims The aim of this study was to examine health-care professionals attitudes towards implantable cardioverter-defibril-
lator (ICD) therapy and issues discussed with patients.
Methods
and results
Survey of 209 health-care professionals providing specialized treatment and care of ICD patients at the five implanting
centres in Denmark. Questions pertained to gender, age, years of experience within the field, knowledge of the
ongoing critical debate on ICD therapy, and personal experience with ICD treatment, and/or sudden cardiac
arrest within family and/or friends. Of all participants, 185 (88.5%) completed the survey. Physicians spent less
time informing patients about ICD treatment prior to implantation (mean min ¼ 17.7+11.2 vs. 28.6+ 19.4;
P, 0.001). They were more likely to discuss clinical issues but less likely to discuss psychosocial issues with patients
compared with non-physicians. Physicians were less likely to believe that their personal attitude towards ICD treat-
ment has no influence on how they deal professionally with patients (27.8 vs. 43.6%; P ¼ 0.04). Physicians and non-
physicians were equally positive towards ICD therapy as primary prophylaxis in ischaemic cardiomyopathy (87.6 vs.
82.1%; P ¼ 0.40) but not in non-ischaemic cardiomyopathy (57.3 vs. 83.9%; P, 0.001). Physicians were more positive
towards ICD therapy as secondary prophylaxis (98.9 vs. 84.2%; P ¼ 0.001) compared with non-physicians.
Conclusions Physicians focus on clinical rather than psychosocial issues when discussing ICD treatment with candidate patients. At
the same time, physicians are more aware that their attitude towards ICD treatment may influence how they deal
professionally with patients compared with non-physicians.
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Introduction
Prophylactic treatment for sudden cardiac death with the implan-
table cardioverter-defibrillator (ICD), either as primary or second-
ary prevention, has an effective therapy, although it is currently the
subject of some debate.1 –3 Implantable cardioverter-defibrillator
treatment can be troublesome due to its side effects, which
includes inappropriate shocks and infection as the most serious
adverse clinical events. Implantable cardioverter-defibrillator treat-
ment is also associated with psychological symptoms, such as
anxiety, depression, and post-traumatic stress, prevalent in 25–
33% patients.4,5 These psychological symptoms may be attributed
to appropriate or inappropriate shocks6,7 and symptomatic heart
failure,8 although recent evidence indicates that the patient’s per-
sonality profile is at least as important as ICD shocks as a determi-
nant of distress.9,10
The personal attitude of health-care providers towards ICD
therapy may play a role in referral of patients for ICD treat-
ment,11,12 but also influence the information and advice they give
to patients who are candidates for ICD implantation. Little is
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known about the general attitude of health-care professionals
involved in the treatment and care of ICD patients,13 towards
ICD therapy and in addition towards specific issues such as deac-
tivation of the ICD in terminally ill patients14– 17 and barriers to
ICD therapy.11
Hence, we conducted a national survey among health-care pro-
fessionals involved in the treatment and care of ICD patients in the
five centres that perform ICD implantations in Denmark. The
survey focused on issues that health-care providers may discuss
with patients prior to ICD implantation and the general attitude
of health-care providers towards ICD therapy.
Methods
Participants and study design
We approached all staff categories, involved in ICD treatment at the
five ICD implanting centres in Denmark, due to the notion that atti-
tudes towards ICD treatment and issues discussed with candidate
patients may vary as a function of professional background. The staff
were divided into the following categories: Electrophysiologists
(implanting ICDs), cardiologists (not implanting ICDs), ICD nurses/
technicians assisting at implant, ICD nurses/technicians in the outpati-
ent clinic, ICD nurses on the ward, and others (e.g. secretary and
engineer). The study group (i.e. the authors) identified the staff in
the five categories within each center. The study was endorsed by
the Danish Working Group of Electrophysiology and Cardiac Pacing.
A questionnaire was mailed to each participant. If the questionnaire
was not returned within 3 weeks, a reminder was mailed together with
a copy of the survey. Handling of the questionnaire and data aggrega-
tion was conducted by an independent research institution, Uni-C
(Aarhus, Denmark), in order to safeguard the participant’s anonymity.
The study group was blinded with regard to individual recognition of
the participant.
Measures
A purpose-designed questionnaire was developed for the current
study by the first (J.B.J.) and the last author (S.S.P.) to examine the
general attitude of health-care providers towards ICD treatment and
issues that they discuss with candidate ICD patients prior to implan-
tation. Questions pertained to gender, age, years of experience
within the field, knowledge of the ongoing critical debate on ICD
therapy2 (i.e. possible overestimation of the clinical benefits of ICD
therapy in terms of a low proportion of patients who experience
appropriate ICD shock but higher than expected rate of compli-
cations4), personal experience with ICD treatment, and/or sudden
cardiac arrest within family and/or friends, and whether there should
be an imaginary biological upper age limit for ICD implantation. The
questionnaire also tapped clinical (e.g. risk of infection) and psychoso-
cial issues (e.g. impact of ICD on body image) discussed with patients
prior to ICD implantation, and the time spent to inform the patient
prior to ICD implantation. Finally, the questionnaire assessed attitudes
towards ICD therapy as primary and secondary prophylaxis in ischae-
mic and non-ischaemic cardiomyopathy, and the belief ‘my personal
attitude towards ICD treatment has no influence on how I deal profes-
sionally with ICD patients’.
Statistical analysis
Prior to statistical analyses, the staff categories were dichotomized into
physicians vs. non-physicians and the age groups into ,50 vs. ≥50
years of age. Nominal variables were analysed with the x2 test,
whereas Student’s t-test was used for continuous variables. Pearson’s
correlation analysis was used to examine the relationship between
years of experience and number of clinical and psychosocial issues dis-
cussed with patients. Logistic regression analysis was used to examine
correlates of the belief ‘my personal attitude towards ICD treatment
has no influence on how I deal professionally with ICD patients’. For
the results of the logistic regression analysis, the odds ratios (ORs)
and their corresponding 95% confidence intervals (CIs) are reported.
All tests were two-tailed, and a P-value of ,0.05 was used to indicate
statistical significance. All data were analysed using SPSS 17.0 for
Windows (SPSS, Inc., Chicago, IL, USA).
Results
Participant characteristics
The questionnaire was distributed to 209 health-care professionals
involved in the treatment and care of ICD patients, with 185
(88.5% response rate) agreeing to participate. The age distribution
of the participants was as follows: ,30 years ¼4.3% (8/185); 30–
39 years ¼14.6% (27/185); 40–49 years ¼40.0% (74/185); 50–59
years ¼30.8% (57/185); and .60 years ¼10.3% (19/185). The dis-
tribution across staff categories was as follows: Electrophysiologists
(implanting ICDs): 12.4% (23/185); cardiologists (not implanting
ICDs): 36.2% (67/185); ICD nurses/technicians assisting at
implant: 18.4% (34/185); ICD nurses/technicians in the outpatient
clinic: 9.2% (17/185); ICD nurses on the ward: 22.2% (41/185);
and others (e.g. secretary, engineer): 1.6% (3/185).
Participant characteristics stratified by physician status are pre-
sented in Table 1. Physicians were more often male, had more
years of experience with ICD therapy, and were also more likely
to be aware of the ongoing critical debate on ICD treatment com-
pared with non-physicians (84.4 vs. 58.9%; P, 0.001). Physicians
were less likely to hold the belief that ‘my personal attitude
towards ICD treatment has no influence on how I deal profession-
ally with ICD patients’ (27.8 vs. 43.6%; P ¼ 0.04). No statistically
significant differences were found on age and personal experience
with ICD treatment and/or sudden cardiac arrest between phys-
icians and non-physicians.
Issues discussed with patients prior to
implantable cardioverter-defibrillator
implantation
Physicians reported that they spent a mean of 17.7+11.2 min to
inform the patient prior to ICD implantation in contrast to non-
physicians who spent a mean of 28.6+19.4 min (P, 0.001). Clini-
cal and psychosocial issues discussed with patients prior to ICD
implantation, stratified by staff category (physicians vs. non-
physicians) are shown in Table 2. Generally, physicians were
more likely to discuss clinical issues with patients, such as risk of
re-operation (63.5 vs. 32.1%; P, 0.001) and the prognostic advan-
tage of having an ICD (100 vs. 89.4%; P ¼ 0.006) compared with
non-physicians. In contrast, physicians were less likely to touch
upon any of the psychosocial issues related to ICD treatment,
including impact on the quality-of-life (74.1 vs. 88.4%; P ¼ 0.03),
sexual activity (20.0 vs. 44.9%; P ¼ 0.001), impact on family and
children (35.7 vs. 78.0%; P, 0.001), impact on body image (16.5
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vs. 46.8%; P, 0.001), and driving (89.4 vs. 97.6%; P ¼ 0.06). No
statistically significant differences were found between implantating
vs. non-implanting physicians on clinical and psychosocial issues
discussed with patients (all P-values .0.05).
There was a tendency for health-care professionals, irrespective
of profession, to discuss more clinical, and psychosocial issues with
patients as a function of having more years of experience with ICD
patients (r ¼ 0.18; P ¼ 0.016).
Influence of personal attitude of
professional caregivers towards
implantable cardioverter-defibrillator
treatment
Of all participants, one-third (35.9%) responded positive to the
statement that ‘my personal attitude towards ICD treatment has
no influence on how I deal professionally with ICD patients’. Cor-
relates of this belief are shown in Table 3, with females and those
older than ≥50 years being more likely to respond positively to
this item, whereas health-care professionals with more experience
with ICD patients and those aware of the current critical debate on
ICD treatment were less likely to hold this belief.
Attitude towards implantable
cardioverter-defibrillator therapy
There was an overall positive attitude among physicians and non-
physicians towards ICD therapy as primary prophylaxis in ischae-
mic cardiomyopathy (87.6 vs. 82.1%; P ¼ 0.40), but a lower pro-
portion of physicians with a positive attitude towards ICD
therapy as primary prophylaxis in non-ischaemic cardiomyopathy
compared with non-physicians (57.3 vs. 83.9%; P, 0.001). On
the other hand, physicians were more inclined to have a positive
attitude towards ICD therapy as secondary prophylaxis (98.9 vs.
84.2%; P ¼ 0.001). In both groups, around 40% endorse that
there should be an upper age limit for ICD therapy (P ¼ 0.76),
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Participant characteristics stratified by staff category (physician vs. non-physician)a
Valid
cases
Total sample
(n 5 185)
Physician
(n5 90)
Non-physician
(n 5 95)
P-value
Female gender 185 51.9% (96) 12.2% (11) 89.5% (85) ,0.001
Age (≥50 years) 185 41.1% (76) 46.7% (42) 35.8% (34) 0.18
Years of experience with ICD therapy, mean+ SD 181 9.5+5.7 10.8+5.4 8.2+5.7 0.002
Aware of current critical debate on ICD therapy 185 71.4% (132) 84.4% (76) 58.9% (56) ,0.001
Personal experience with ICD treatment and/or sudden cardiac arrestb 185 29.7% (55) 31.1% (28) 28.4% (27) 0.81
Holding the belief that ‘my personal attitude towards ICD treatment has no
influence on how I deal professionally with ICD patients’
184 35.9% (66) 27.8% (25) 43.6% (41) 0.04
aListed as % (n) unless otherwise indicated.
bFamily member/friend having experienced a sudden cardiac arrest or family member/friend having an ICD.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Clinical and psychosocial issues discussed with patients prior to ICD implantation, stratified by staff category
(physician vs. non-physician)a
Valid cases Physician (n 5 90) Non-physician (n5 95) P-value
Clinical issues
Risk of infection 169 87.1% (74) 89.3% (75) 0.83
Risk of re-operation 166 63.5% (54) 32.1% (26) ,0.001
Risk of shock 170 97.6% (83) 96.5% (82) 1.00
Risk of device recall 158 20.0% (17) 11.0% (8) 0.18
Prognostic advantage 170 100.0% (85) 89.4% (76) 0.006
No. of items with positive endorsement, mean+ SD 185 3.48+1.24 2.81+1.23 ,0.001
Psychosocial issues
Impact on the quality-of-life 171 74.1% (63) 88.4% (76) 0.03
Impact on sexual activity 163 20.0% (17) 44.9% (35) 0.001
Impact on family/children 166 35.7% (30) 78.0% (64) ,0.001
Impact on body image 164 16.5% (14) 46.8% (37) ,0.001
Impact on driving 169 89.4% (76) 97.6% (82) 0.06
No. of items with positive endorsement, mean+ SD 185 2.22+1.32 3.09+1.58 ,0.001
aListed as % (n) unless otherwise indicated.
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with physicians and non-physicians proposing that this upper limit
be 82.2 and 80.7 years (P ¼ 0.24), respectively.
Discussion
There has been a rise in the number of physician surveys focusing
on ICD therapy in terminally ill patients. To our knowledge,
however, this is the first study to examine the general attitudes
of health-care providers who are involved in the treatment and
care of ICD patients, and the extent to which they cover a
broad range of ICD-related issues, capturing both clinical and psy-
chosocial issues, when discussing ICD implantation with candidate
patients. Generally, we found that health-care providers in ICD
implanting centres had a positive attitude (.80%) towards ICD
therapy. The rate of ICD implants in Denmark has increased
from 105 per million inhabitants in 2005 to 207 in 2009. The pro-
portion of patients with a primary prophylactic indication has
increased from 8% in 2005 to 53% in 2009.18 These figures also
reflect the positive attitude among Danish physicians towards
implantation of primary prophylactic ICDs. Implantation of an
ICD as primary prophylaxis in patients with non-ischaemic cardio-
myopathy was the only exception, with only 57% of physicians
endorsing this indication. This attitude might be rooted in random-
ized controlled trials in patients with non-ischaemic cardiomyopa-
thy, showing only marginal benefits of ICD therapy.19,20 This
despite primary prophylaxis in non-ischaemic cardiomyopathy is
being classified together with primary prophylaxis in ischaemic
dilated cardiomyopathy and secondary prophylaxis as a class I indi-
cation in current guidelines.21 The ongoing DANISH study (A
DANish randomized, controlled, multicentre study to assess the
efficacy of ICD in patients with non-ischaemic Systolic Heart
failure on mortality) will likely show whether ICD implantation
for primary prophylaxis in non-ischaemic dilated cardiomyopathy
is beneficial.
In the current study, physicians generally spent less time inform-
ing the patient about ICD treatment prior to implantation than
non-physicians. Physicians were more likely than non-physicians
to discuss clinical issues (e.g. risk of re-operation) with patients
but less likely to discuss psychosocial and emotional issues (e.g.
impact of ICD on the quality-of-life and body image). These find-
ings corroborate but also extend those reported by Sears
et al.13 who asked physicians and nurses and other health-care pro-
viders to rate the concerns of their patients and the extent to
which they could manage these patient concerns. In their survey,
physicians were less likely to observe that their patients would
be concerned about emotional problems, such as fear, anxiety,
and depression, and also considered themselves less capable of
managing such emotional problems in their patients compared
with nurses and other health-care providers.13 On the basis of
the data gathered for the current survey, we cannot determine
whether physicians’ tendency to focus more on clinical aspects
related to the device but less so emotional issues is attributable
to an inability to cope with emotional problems, or simply reflects
a greater importance given to clinical issues. Furthermore, there
may be important differences in the information provided to
patients with primary prophylactic indication when compared
with secondary prophylactic indication, as the patient in the
latter situation already have experienced a life-threatening event,
and thus only need a short introduction to ICD therapy.
However, the study did not include data on the level of infor-
mation stratified by indication.
Given the evolvement and complexity of device therapy, with
increases in device advisories and complications, including inap-
propriate shocks, and the associated negative publicity in the
press leading to a refusal of ICD therapy in some cases as reported
in the USA,2 it seems particularly important to broach these issues
with patients head on and at an early stage. The physicians in our
survey do prioritize these clinical issues, although we cannot deter-
mine whether they also discuss the potential impact of these
device-related complications specifically with respect to psycho-
logical functioning and the quality-of-life. This is important from
the point of view of secondary prevention, given that psychological
factors have been shown to increase the risk of ventricular tachyar-
rhythmias and mortality in ICD patients.6,22,23 It is possible that a
proactive, prophylactic psycho-educational approach may prove
to be beneficial in this regard, although this needs to be confirmed
in future studies.24,25 The availability of a good multidisciplinary
team that also includes a psychologist, who can deal with the
more severe levels of distress, may very well be beneficial to
patients who find it difficult to adjust to life with device therapy.
The inclusion of a psychologist as part of the team has several
advantages, including the implicit message to patients that seeing
a psychologist is nothing out of the ordinary. In addition, physicians
may be less fearful of broaching emotional issues, as they know
that there is a psychologist on board the team to whom they
can refer patients if necessary. Management strategies for dis-
tressed patients are available and have shown to be successful in
reducing anxiety and improving their quality-of-life.26,27
This study has some limitations. The study only approached
referring physicians for ICD treatment from within ICD implanting
centres, and a potential bias towards a positive attitude towards
ICD therapy cannot be excluded. As is the case with all surveys,
there is a risk that participants provide socially desirable
answers. However, the use of an independent research institution,
Uni-C (Aarhus, Denmark), to handle the questionnaire and data
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Correlates of the belief ‘my personal attitude
towards ICD treatment has no influence on how I deal
professionally with ICD patients’
Correlates OR 95% CI P-value
Female, gender 3.92 1.26–12.17 0.02
Age ≥50 years 6.86 2.80–16.83 ,0.001
Physician 1.82 0.60–5.55 0.29
Years experience with ICD patients 0.86 0.80–0.93 ,0.001
Personal experience with ICD
treatment and/or sudden cardiac
arresta
1.00 0.46–2.16 1.00
Aware of current critical debate on
ICD treatment
0.37 0.17–0.82 0.01
aFamily member/friend having experienced a sudden cardiac arrest or family
member/friend having an ICD.
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aggregation is likely to have kept this risk to a minimum. Despite
these limitations, the study also has several strengths. These
include the high response rate of 88.5% and the generalisability
of the findings to all health-care providers involved in the treat-
ment and care of ICD patients in Denmark. Most other surveys
on issues related to ICD treatment, such as deactivation of the
device, tend to have focused on physicians only or to have a rela-
tively poor response rate.11,14,28
In conclusion, this study reporting on the results of a national
survey of attitudes of health-care providers involved in the treat-
ment and care of ICD patients in Denmark showed that ICD treat-
ment was generally well accepted, except from inpatients with
non-ischaemic cardiomyopathy. Physicians tended to focus more
on clinical rather than psychosocial issues when discussing ICD
treatment with candidate patients compared with non-physicians,
and also to spend less time providing information on ICD treat-
ment to patients prior to implantation. At the same time, phys-
icians were more aware that their attitude towards ICD
treatment might influence how they deal professionally with
patients compared with non-physicians. The influence of attitudes
of health-care providers towards ICD treatment for patients
should not be underestimated and should be the subject of
future research.
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